l ‐Arginine‐Modified CoWO 4 /FeWO 4 S‐Scheme Heterojunction Enhances Ferroptosis against Solid Tumor
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202203092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Zhuoran Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Photochemical Biomaterials and Energy Storage Materials, Heilongjiang Province and College of Chemistry and Chemical Engineering, H…. Hauptthemen laut MEDLINE: Ferroptosis, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Ferroptosis has recently attracted much attention as an anti‐tumor therapy. Evidence suggests that ferroptosis can induce oxidative stress and accumulation of lethal lipid peroxides in cancer cells, leading to cell damage. However, unsuitable pH, H 2 O 2 levels, and high glutathione (GSH) expression in the tumor microenvironment hinder the development of ferroptosis‐mediated therapy. In this study, an l ‐arginine ( l ‐arg)‐modified CoWO 4 /FeWO 4 (CFW) S‐scheme heterojunction is strategically designed and constructed for ultrasound (US)‐triggered sonodynamic‐ and gas therapy‐induced ferroptosis. CFW not only has excellent Fenton‐catalytic activity, outstanding GSH consumption capacity, and excellent ability to overcome tumor hypoxia, but its S‐scheme heterostructure can also avoid the rapid combination of electron (e) and hole (h + ) pairs, thereby enhancing the sonodynamic effects. As a precursor of nitric oxide (NO), l ‐arg is modified on the surface of CFW (CFW@ l ‐arg) to achieve controlled NO release under US irradiation, thereby enhancing ferroptosis. In addition, poly(allylamine hydrochloride) is further modified on the surface of CFW@ l ‐arg to stabilize l ‐arg and achieve controllable NO release. Both in vitro and in vivo results demonstrate that such a multifunctional therapeutic nanoplatform can achieve high therapeutic efficacy through sonodynamic and gas therapy‐enhanced ferroptosis. This designed oncotherapy nanoplatform provides new inspiration for ferroptosis‐mediated therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Photochemical Biomaterials and Energy Storage Materials, Heilongjiang Province and College of Chemistry and Chemical Engineering, Harbin Normal University, Harbin, 150025, China.
- College of Life Science and Agriculture Forestry, Qiqihar University, Qiqihar, 161006, China.
ORCID-Profile: Wei Guo
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, Z., Yang, C., Yang, D., Zhang, Y., Yang, Q., Qu, F., & Guo, W. (2023). l ‐Arginine‐Modified CoWO 4 /FeWO 4 S‐Scheme Heterojunction Enhances Ferroptosis against Solid Tumor. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202203092
Vancouver
Yang Z, Yang C, Yang D, Zhang Y, Yang Q, Qu F, et al. l ‐Arginine‐Modified CoWO 4 /FeWO 4 S‐Scheme Heterojunction Enhances Ferroptosis against Solid Tumor. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202203092
BibTeX
@article{Yang2023,
author = {Yang, Zhuoran and Yang, Chunyu and Yang, Dan and Zhang, Ye and Yang, Qingzhu and Qu, Fengyu and Guo, Wei},
title = {l ‐Arginine‐Modified CoWO 4 /FeWO 4 S‐Scheme Heterojunction Enhances Ferroptosis against Solid Tumor},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202203092}
}
EUVIMED